Title: SEX
1SEX
- Differences in Schizophrenia
- Adam Taylor
2- Roses are red,
- Violets are blue,
- Im a schizophrenic
- And so am I
-
3Basics of Schizophrenia
- Approximately 1 of population affected
- Knows no cultural boundaries
- Generally presents around 18-30
- Can be lifelong, even with treatment
- Treatment is not a cure
4Symptoms
- Positive symptoms
- Hallucinations
- Delusions
- Negative symptoms
- Loss of affect and enjoyment
- Social withdrawal
- Cognitive symptoms
- Thought disorder
- General perception distortion
5Vulnerability-Stress Model
Principles of Neuropsychopharmacology
6Possible Causes
- Genetic evidence
- Monozygotic twin of a schizophrenic has 40-50 of
becoming schizophrenic - Child of a schizophrenic has 10 risk
7Genetic Risk
Principles of Neuropsychopharmacology
8Possible Causes
- Genetic evidence
- Monozygotic twin of a schizophrenic has 40-50 of
becoming schizophrenic - Child of a schizophrenic has 10 risk
- Dopamine
- Antipsychotics block DA transmission
9Dopamine Hypothesis
- DA agonists exacerbate symptoms and can produce
schizophrenia-like symptoms - Plasma HVA levels in CSF are low in patients with
worse negative symptoms - Kahn (1995) suggest hypodopamine in mesocortical
neurons and hyperdopamine in mesolimbic neurons
10More Causes
- Developmental defect
- Evidence that certain stressors of the mother,
such as flu during pregnancy, lead to a higher
risk - Animal models utilize prenatal stress to develop
schizophrenic rats
11Neurodevelopmental Model
Principles of Neuropsychopharmacology
12More Causes
- Developmental defect
- Evidence that certain stressors of the mother,
such as flu during pregnancy lead to a higher
risk - Animal models utilize prenatal stress to develop
schizophrenic rats - Serotonin (5-HT)
- Low levels of 5HIAA in patients with negative
symptoms - Hallucinogens stimulate 5-HT2a receptors leading
to enhanced glutamate transmission in prefrontal
cortex - PCP
- NMDA antagonist produces psychotic effects,
blocked by 5-HT2a antagonists
13Anatomical Defects
- Enlarged ventricles
- Prefrontal cortex atrophy
- Decreased hippocampal volume
14Treatment Basics
- Typical antipsychotics
- Chlorpromazine, haloperidol
- DA antagonists
- Treat positive symptoms well
- Tardive dyskinesia
- Atypical antipsychotics
- Clozapine, risperidone
- 5-HT2a antagonist
- D2 antagonist
- Adrenergic and histaminergic antagonist
- Treat positive, negative and cognitive symptoms
15Effects of Antipsychotics
Principles of Neuropsychopharmacology
16Antipsychotic Receptor Effects
Principles of Neuropsychopharmacology
17Are There Sex Differences?
18Age of Onset
Hafner, Psychoneuroendocrinology, 2003
19Are There Sex Differences?
- Males have earlier onset
- No difference in prevalence
- Women typically show better response to
medication - Some Differences in Behavior
- Some studies suggest men have more negative
symptoms and women more positive (Castle, 1999)
while others say no difference (e.g. Moldin,
2000) - Probably due to experimental differences
20Gender Differences in Behavior
21Behavior by Sex
Hafner, Psychoneuroendocrinology, 2003
22Gender Differences in Symptoms
23Neuropsychological Functioning
Goldstein et al., Am J Psychiatry, 1998
24Why Women?
- Women are generally older and have more social
skills and understanding at disease onset - Gastric emptying is slower than men
- Antipsychotics may be absorbed more efficiently
- Higher cerebral blood flow may distribute drugs
better in women - Higher body fat in women
- Antipsychotic drugs are highly lipophillic and as
so may dissipate more slowly in women
25Estrogen Hypothesis
- Women have later onset
- Better response to treatment
- Some women report fluctuations in symptoms over
menstrual cycle - A cohort of women who become afflicted after
menopause - Higher doses of medication in postmenopausal
women
26Late-Onset in Women
27Effects of Estrogen
- May mimic typical antipsychotics by blocking D2
receptors - May mimic atypical antipsychotics by decreasing
5-HT2 receptor sensitivity (Hafner, 2003) - Estrogen protects against cell death
28Effect of Estrogen Levels
- Global cognitive score
- Average of six cognitive domain scores
- Language, Executive, verbal memory, spatial
memory, concentration and sensory-perceptual
Hoff et al., Am J Psychiatry, 2001
29Effect of Estrogen
Hafner, Psychoneuroendocrinology, 2003
30Effect of Estrogen
Hafner, Psychoneuroendocrinology, 2003
31Effect of Estrogen Treatment
Kulkarni et al., Schiz Res, 1996
32Effect of Estrogen Treatment
__ antipsychotic 100mcg estradiol ---
antipsychotic 50mcg estradiol antipsychotic
placebo
Kulkarni et al., Schiz Res, 2001
33The Conclusions Slide
- Schizophrenia is a chronic, disabling disorder
characterized by many symptoms - Differences between gender are somewhat
questionable - Estrogen seems to play a protective role in
female schizophrenics - Adjunctive estrogen treatment may be beneficial